Silexion Therapeutics (SLXN) Q3 2025 Earnings

Aug 12Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-7.4
-5.19
-2.98
-0.77

Details

Expected EPS
-3.15
Actual EPS
-4.32
Surprise EPS
-1.17
Surprise Percent
-37.14%

Description

⁨Silexion Therapeutics⁩ (⁦SLXN⁩) has reported earnings of ⁦-4.32⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts